|
US5268358A
(en)
|
1988-12-08 |
1993-12-07 |
Cor Therapeutics, Inc. |
PDGF receptor blocking peptides
|
|
US7144731B2
(en)
|
1989-10-16 |
2006-12-05 |
Amgen Inc. |
SCF antibody compositions and methods of using the same
|
|
US20050276784A1
(en)
|
1990-08-27 |
2005-12-15 |
Solan-Kettering Institute For Cancer Research |
Ligand for the c-kit receptor and methods of use thereof
|
|
US20030125519A1
(en)
|
1990-08-27 |
2003-07-03 |
Peter Besmer |
Ligand for the c-kit receptor and methods of use thereof
|
|
ES2147729T3
(es)
|
1991-01-31 |
2000-10-01 |
Cor Therapeutics Inc |
Dominios de la region extracelular de polipeptidos receptores de factor de crecimiento derivado de plaquetas humano.
|
|
DK0578774T3
(da)
|
1991-04-05 |
1999-04-26 |
Univ Washington |
Monoklonale antistoffer mod stamcellefaktor-receptorer
|
|
US5545533A
(en)
|
1991-05-25 |
1996-08-13 |
Boehringer Mannheim Gmbh |
Monoclonal antibodies against c-kit and method of detecting a malignancy using c-kit specific antibodies
|
|
DE4205148A1
(de)
|
1991-05-25 |
1993-01-21 |
Boehringer Mannheim Gmbh |
Monoklonale antikoerper gegen c-kit
|
|
EP0619738B1
(en)
|
1991-12-02 |
2003-07-09 |
Millennium Pharmaceuticals, Inc. |
Inhibitory immunoglobulin polypeptides to human pdgf beta receptor
|
|
US5817310A
(en)
|
1991-12-02 |
1998-10-06 |
Cor Therapeutics, Inc. |
Inhibitory immunoglobulin polypeptides to human PDGF beta receptor
|
|
EP0548867A2
(en)
|
1991-12-23 |
1993-06-30 |
Yeda Research And Development Co. Ltd. |
Soluble stem cell factor (SFC)-receptor
|
|
US6001803A
(en)
|
1992-04-23 |
1999-12-14 |
Sloan-Kettering Institute For Cancer Research |
Composition of c-kit ligand, GM-CSF, and TNF-α and method of use
|
|
US6448077B1
(en)
|
1994-02-10 |
2002-09-10 |
Imclone Systems, Inc. |
Chimeric and humanized monoclonal antibodies specific to VEGF receptors
|
|
US5911988A
(en)
|
1995-04-28 |
1999-06-15 |
Bayer Corporation |
Method for treating asthma using SCF antibody
|
|
US6936259B2
(en)
|
1995-06-08 |
2005-08-30 |
University Of Saskatchewan |
CAMP factor of Streptococcus uberis
|
|
DE19600589C1
(de)
|
1996-01-10 |
1997-01-16 |
Univ Eberhard Karls |
Antikörper A3C6E2
|
|
US5882644A
(en)
|
1996-03-22 |
1999-03-16 |
Protein Design Labs, Inc. |
Monoclonal antibodies specific for the platelet derived growth factor β receptor and methods of use thereof
|
|
US5910417A
(en)
|
1996-05-31 |
1999-06-08 |
National Jewish Center For Immunology And Respiratory Medicine |
Regulation of cytokine production in a hematopoietic cell
|
|
AU6763098A
(en)
|
1997-03-19 |
1998-10-12 |
Yale University |
Methods and compositions for stimulating apoptosis and cell death or for inhibiting cell growth and cell attachment
|
|
DE19727814C1
(de)
|
1997-06-30 |
1998-10-01 |
Univ Eberhard Karls |
Anitkörper 4G8B4B12
|
|
US7361336B1
(en)
|
1997-09-18 |
2008-04-22 |
Ivan Bergstein |
Methods of cancer therapy targeted against a cancer stem line
|
|
AU9692498A
(en)
|
1997-10-10 |
1999-05-03 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Complex of biotinylated viral vector and ligand for targeted gene delivery
|
|
WO2000061637A1
(en)
|
1999-04-14 |
2000-10-19 |
Smithkline Beecham Corporation |
Erythropoietin receptor antibodies
|
|
US6576812B1
(en)
|
1999-05-06 |
2003-06-10 |
The Trustees Of Columbia University In The City Of New York |
Compound screening assays using a transgenic mouse model of human skin diseases
|
|
US6989248B2
(en)
|
1999-05-06 |
2006-01-24 |
The Trustees Of Columbia University In The City Of New York |
Methods of use of compounds which inhibit the stem cell signaling pathway
|
|
EP1227846A2
(en)
|
1999-11-12 |
2002-08-07 |
ADVANCED RESEARCH AND TECHNOLOGY INSTITUTE, Inc. |
Methods for inhibiting neurofibromatosis type 1 (nf1)
|
|
EP1255536B1
(en)
*
|
1999-12-22 |
2006-06-28 |
Sugen, Inc. |
Indolinone derivatives for modulation of c-kit tyrosine protein kinase
|
|
US8088060B2
(en)
|
2000-03-15 |
2012-01-03 |
Orbusneich Medical, Inc. |
Progenitor endothelial cell capturing with a drug eluting implantable medical device
|
|
US20110091428A1
(en)
|
2000-07-31 |
2011-04-21 |
New York Medical College |
Compositions of adult organ stem cells and uses thereof
|
|
US6914947B2
(en)
|
2001-02-28 |
2005-07-05 |
Telefonaktiebolaget L M Ericsson (Publ) |
Method and apparatus for handling time-drift
|
|
WO2002084290A1
(fr)
|
2001-04-13 |
2002-10-24 |
Chugai Seiyaku Kabushiki Kaisha |
Procede permettant de quantifier l'expression d'antigenes
|
|
JP2003048831A
(ja)
|
2001-08-02 |
2003-02-21 |
Suntory Ltd |
脳機能の低下に起因する症状あるいは疾患の予防又は改善作用を有する組成物
|
|
EP2277991A1
(en)
|
2001-08-21 |
2011-01-26 |
Ventana Medical Systems, Inc. |
Method and quantification assay for determining c-kit/SCF/pAKT status
|
|
CA2471140A1
(en)
|
2001-12-20 |
2003-07-03 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to trail receptors
|
|
US6998391B2
(en)
|
2002-02-07 |
2006-02-14 |
Supergen.Inc. |
Method for treating diseases associated with abnormal kinase activity
|
|
AU2003217912A1
(en)
|
2002-03-01 |
2003-09-16 |
Xencor |
Antibody optimization
|
|
AU2003237332A1
(en)
|
2002-06-03 |
2003-12-19 |
Centocor, Inc. |
Anti-relp fusion antibodies, compositions, methods and uses
|
|
WO2004002425A2
(en)
|
2002-06-28 |
2004-01-08 |
Bio Transplant, Inc. |
Process for promoting graft acceptance by depletion of hematopoietic stem cells
|
|
CA2514979A1
(en)
|
2003-01-31 |
2004-09-02 |
Celldex Therapeutics, Inc. |
Antibody vaccine conjugates and uses therefor
|
|
US20050281828A1
(en)
|
2003-03-04 |
2005-12-22 |
Bowdish Katherine S |
Method of treating autoimmune disease by inducing antigen presentation by tolerance inducing antigen presenting cells
|
|
WO2005003302A2
(en)
*
|
2003-06-17 |
2005-01-13 |
Medimmune, Inc. |
Novel methods to modulate mast cells
|
|
US7303893B1
(en)
|
2003-08-28 |
2007-12-04 |
Takeda San Diego, Inc. |
Crystallization of c-KIT tyrosine kinase leading to autoinhibited crystal structure
|
|
US8133733B2
(en)
|
2003-10-24 |
2012-03-13 |
Gencia Corporation |
Nonviral vectors for delivering polynucleotides to target tissues
|
|
WO2005057223A2
(en)
|
2003-12-04 |
2005-06-23 |
Applied Research Systems Ars Holding N.V. |
Methods for identifying modulators of active kit tyrosine kinase receptor
|
|
MX350383B
(es)
|
2004-01-09 |
2017-09-04 |
Pfizer |
Anticuerpos contra madcam.
|
|
DE112005001317A5
(de)
|
2004-03-27 |
2007-05-24 |
Klein, Hanns-Georg, Dr. |
Polymorphismen im NOD2/Card15 Gen
|
|
ES2375481T3
(es)
|
2004-03-30 |
2012-03-01 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Anticuerpos biespecíficos para elegir como diana células que participan en reacciones de tipo alérgico, composiciones y usos de los mismos.
|
|
CN1997382A
(zh)
|
2004-05-05 |
2007-07-11 |
梅里麦克制药股份有限公司 |
调节生物活性的双特异性结合剂
|
|
US7329495B2
(en)
|
2004-06-09 |
2008-02-12 |
Board Of Regents, The University Of Texas System |
Mutations in KIT confer imatinib resistance in gastrointestinal stromal tumors
|
|
CA2570817A1
(en)
*
|
2004-06-17 |
2006-01-26 |
Plexxikon, Inc. |
Azaindoles modulating c-kit activity and uses therefor
|
|
AU2005271892A1
(en)
|
2004-07-10 |
2006-02-16 |
Alexion Pharmaceuticals, Inc. |
Methods for discovering antibodies specific to cancer cells and antibodies discovered thereby
|
|
PL1781321T3
(pl)
|
2004-08-02 |
2014-07-31 |
Zenyth Operations Pty Ltd |
Sposób leczenia raka zawierający antagonistę VEGF-B
|
|
CA2575791A1
(en)
|
2004-08-03 |
2006-02-16 |
Dyax Corp. |
Hk1-binding proteins
|
|
CA2599606A1
(en)
|
2005-02-23 |
2006-08-31 |
Merrimack Pharmaceuticals, Inc. |
Bispecific binding agents for modulating biological activity
|
|
US20060222634A1
(en)
|
2005-03-31 |
2006-10-05 |
Clarke Diana L |
Amnion-derived cell compositions, methods of making and uses thereof
|
|
CA2606081C
(en)
|
2005-04-26 |
2013-09-17 |
Markus M. Heiss |
Combination of the application of antibodies for immunostimulation together with glucocorticoids
|
|
AU2006264567A1
(en)
|
2005-05-05 |
2007-01-11 |
Valorisation Hsj, Societe En Commandite |
Cytokine receptor modulators and uses thereof
|
|
WO2007014943A2
(en)
|
2005-08-01 |
2007-02-08 |
Ares Trading S.A. |
Therapy for neurological diseases
|
|
WO2008048671A1
(en)
|
2006-10-18 |
2008-04-24 |
University Of Illinois |
Embryonic-like stem cells derived from adult human peripheral blood and methods of use
|
|
ES2577535T3
(es)
|
2005-10-21 |
2016-07-15 |
Regents Of The University Of California |
Mutaciones del oncogén de C-kit en melanomas
|
|
EP1790664A1
(en)
|
2005-11-24 |
2007-05-30 |
Ganymed Pharmaceuticals AG |
Monoclonal antibodies against claudin-18 for treatment of cancer
|
|
US20090304625A1
(en)
|
2006-01-18 |
2009-12-10 |
Ahsan Husain |
Modulators of cardiac cell hypertrophy and hyperplasia
|
|
EP2606890A1
(en)
|
2006-04-05 |
2013-06-26 |
Novartis AG |
Combinations comprising BCR-ABL/C-KIT/PDGF-R TK inhibitors for treating cancer
|
|
TWI395754B
(zh)
|
2006-04-24 |
2013-05-11 |
Amgen Inc |
人類化之ｃ-ｋｉｔ抗體
|
|
JP2010500283A
(ja)
|
2006-05-31 |
2010-01-07 |
ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー |
チロシンキナーゼ阻害剤を用いて炎症性疾患を治療する方法
|
|
US7919092B2
(en)
|
2006-06-13 |
2011-04-05 |
Oncomed Pharmaceuticals, Inc. |
Antibodies to notch receptors
|
|
JP2009540018A
(ja)
|
2006-06-13 |
2009-11-19 |
ザイモジェネティクス， インコーポレイテッド |
Ｉｌ−１７およびｉｌ−２３アンタゴニストならびにその使用方法
|
|
EA200900573A1
(ru)
|
2006-10-20 |
2009-10-30 |
АйАрЭм ЭлЭлСи |
Композиции и способы для модуляции рецепторов c-kit и pdgfr
|
|
US7959942B2
(en)
|
2006-10-20 |
2011-06-14 |
Orbusneich Medical, Inc. |
Bioabsorbable medical device with coating
|
|
ES2882360T3
(es)
|
2006-11-03 |
2021-12-01 |
Univ Leland Stanford Junior |
Inmunoempobrecimiento selectivo de un nicho de células madre endógenas para injerto
|
|
US20100029674A1
(en)
|
2006-11-17 |
2010-02-04 |
Innate Pharma, S.A. |
Methods of Using Phosphoantigen for the Treatment of Cancer
|
|
WO2008115300A1
(en)
|
2006-12-01 |
2008-09-25 |
Apocell, Inc. |
C-kit phosphorylation in cancer
|
|
JP5885012B2
(ja)
*
|
2007-01-19 |
2016-03-15 |
バイエル・ヘルスケア・エルエルシーＢａｙｅｒ ＨｅａｌｔｈＣａｒｅＬＬＣ |
Ｋｉｔ阻害剤に対して獲得した抵抗性を有する癌の処置
|
|
CA2703136A1
(en)
*
|
2007-03-12 |
2008-09-18 |
Vasgene Therapeutics, Inc. |
Use of ephb4 as a diagnostic marker and a therapeutic target for ovarian cancer
|
|
AU2008232354B9
(en)
|
2007-03-27 |
2012-07-26 |
Synta Pharmaceuticals Corp. |
Triazinone and diazinone derivatives useful as Hsp90 inhibitors
|
|
US20110268776A1
(en)
|
2007-04-25 |
2011-11-03 |
Schapira Jay N |
Programmed-release, nanostructured biological construct for stimulating cellular engraftment for tissue regeneration
|
|
HUE036885T2
(hu)
*
|
2007-05-14 |
2018-08-28 |
Astrazeneca Ab |
Eljárás a bazofil-szint csökkentésére
|
|
AR066660A1
(es)
|
2007-05-23 |
2009-09-02 |
Genentech Inc |
Prevencion y tratamiento de condiciones del ojo asociadas con su complemento
|
|
CN101801407B
(zh)
|
2007-06-05 |
2013-12-18 |
耶鲁大学 |
受体酪氨酸激酶抑制剂及其使用方法
|
|
WO2009021137A2
(en)
|
2007-08-07 |
2009-02-12 |
Purdue Research Foundation |
Kinase inhibitors and uses thereof
|
|
US20100196923A1
(en)
|
2007-08-14 |
2010-08-05 |
Anthony Atala |
Pluripotent adult stem cells
|
|
US8569262B2
(en)
|
2007-11-02 |
2013-10-29 |
Momenta Pharmaceuticals, Inc. |
Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
|
|
WO2009073139A2
(en)
|
2007-11-28 |
2009-06-11 |
Osi Pharmaceuticals, Inc. |
Combined treatment with an egfr kinase inhibitor and an inhibitor of c-kit
|
|
WO2009082624A2
(en)
|
2007-12-10 |
2009-07-02 |
Zymogenetics, Inc. |
Antagonists of il-17a, il-17f, and il-23 and methods of using the same
|
|
AU2008338421A1
(en)
|
2007-12-17 |
2009-06-25 |
Dyax Corp. |
Compositions and methods for treating osteolytic disorders comprising MMP-14 binding proteins
|
|
US8426396B2
(en)
|
2008-01-08 |
2013-04-23 |
Shriners Hospitals For Children |
Treatment for achondroplasia
|
|
US20110059091A1
(en)
|
2008-02-04 |
2011-03-10 |
Xiao-Jia Chang |
Inhibitors of oncogenic isoforms and uses thereof
|
|
WO2009135001A2
(en)
|
2008-04-30 |
2009-11-05 |
University Of Pittsburgh- Commonwealth System Of Higher Education |
Methods and compositions for regulating th2 and th17 responses
|
|
EP2297305A4
(en)
|
2008-05-15 |
2013-03-13 |
Univ Miami |
ISOLATION OF STEM CELL PROCESSORS AND EXPANSION UNDER NON-TERMS OF CONDITION
|
|
MX2010013683A
(es)
*
|
2008-06-13 |
2011-04-26 |
Novartis Ag |
Bencimidazoles sustituidos para neurofibromatosis.
|
|
WO2009158447A2
(en)
*
|
2008-06-27 |
2009-12-30 |
Indiana University Research And Technology Corporation |
Materials and methods for suppressing and/or treating neurofibroma and related tumors
|
|
KR20110039220A
(ko)
|
2008-06-30 |
2011-04-15 |
교와 핫꼬 기린 가부시키가이샤 |
항ｃｄ27 항체
|
|
US20110293574A1
(en)
|
2008-09-26 |
2011-12-01 |
Chute John P |
Hematopoietic stem cell growth factor
|
|
MX2011004165A
(es)
|
2008-10-22 |
2011-08-08 |
Genentech Inc |
Celulas madre de prostata y sus usos.
|
|
RU2015130665A
(ru)
|
2008-11-19 |
2018-12-24 |
Антродженезис Корпорейшн |
Амниотические адгезивные клетки
|
|
WO2010065685A1
(en)
|
2008-12-04 |
2010-06-10 |
Cleveland Clinic |
Method of treating c-kit positive relapsed acute myeloid leukemia
|
|
US20100204058A1
(en)
|
2009-01-28 |
2010-08-12 |
Howard Yuan-Hao Chang |
Profiling for Determination of Response to Treatment for Inflammatory Disease
|
|
JP2012525149A
(ja)
|
2009-04-27 |
2012-10-22 |
オンコメッド ファーマシューティカルズ インコーポレイテッド |
ヘテロ多量体分子を作製するための方法
|
|
PE20120475A1
(es)
|
2009-05-12 |
2012-05-05 |
Pfizer |
Anticuerpos especificos para dkk-1
|
|
KR101224468B1
(ko)
|
2009-05-20 |
2013-01-23 |
주식회사 파멥신 |
신규한 형태의 이중표적항체 및 그 용도
|
|
WO2010136508A2
(en)
|
2009-05-28 |
2010-12-02 |
Glaxo Group Limited |
Stem cell targeting
|
|
NZ599866A
(en)
*
|
2009-11-06 |
2014-09-26 |
Plexxikon Inc |
Compounds and methods for kinase modulation, and indications therefor
|
|
IN2012DN05014A
(https=)
|
2009-12-29 |
2015-10-02 |
Univ Yale |
|
|
BR112012016992A2
(pt)
|
2010-01-14 |
2019-09-24 |
Univ Yale |
"funcionalidade que se liga a uma interface de contato assimétrico de um recpetor de tirosina quinase (rtk), hibridoma, composição farmacêutica, uso de uma quantidade efixaz da funcionalidade, método para identificar uma funcionalidade que se liga a uma interface de contato assimétrico de um receptor de tirosina quinase (rtk), e, molécula pequena".
|
|
US20130011406A1
(en)
|
2010-03-26 |
2013-01-10 |
Kolltan Pharmaceuticals, Inc. |
Anti-kit antibodies and uses thereof
|
|
AU2012204846B2
(en)
|
2011-01-06 |
2016-09-08 |
Complix Nv |
Alphabodies specifically binding to cytokines or growth factors and/or cytokine or growth factor receptors
|
|
US9540443B2
(en)
|
2011-01-26 |
2017-01-10 |
Kolltan Pharmaceuticals, Inc. |
Anti-kit antibodies
|
|
AR086044A1
(es)
*
|
2011-05-12 |
2013-11-13 |
Imclone Llc |
Anticuerpos que se unen especificamente a un dominio extracelular de c-kit y usos de los mismos
|
|
JP6104257B2
(ja)
|
2011-10-14 |
2017-03-29 |
メドイミューン・リミテッドＭｅｄＩｍｍｕｎｅ Ｌｉｍｉｔｅｄ |
ピロロベンゾジアゼピンおよびそのコンジュゲート
|
|
WO2013177481A1
(en)
|
2012-05-25 |
2013-11-28 |
Immunogen, Inc. |
Benzodiazepines and conjugates thereof
|
|
CN116574185A
(zh)
|
2012-07-25 |
2023-08-11 |
塞尔德克斯医疗公司 |
抗kit抗体及其用途
|
|
WO2015050959A1
(en)
|
2013-10-01 |
2015-04-09 |
Yale University |
Anti-kit antibodies and methods of use thereof
|
|
WO2015112822A1
(en)
|
2014-01-24 |
2015-07-30 |
Kolltan Pharmaceuticals, Inc. |
Antibody-drug conjugates targeting kit receptor and uses thereof
|
|
CN113908269A
(zh)
|
2014-05-23 |
2022-01-11 |
塞尔德克斯医疗公司 |
嗜酸性粒细胞或肥大细胞相关病症的治疗
|